(19)
(11) EP 1 418 936 A2

(12)

(88) Date of publication A3:
25.03.2004

(43) Date of publication:
19.05.2004 Bulletin 2004/21

(21) Application number: 02724144.7

(22) Date of filing: 07.05.2002
(51) International Patent Classification (IPC)7A61K 38/20, A61K 39/395, A61K 31/7125, A61K 38/45, A61K 38/17, A61K 31/00, C12N 15/11, C12Q 1/68, G01N 33/50, C12N 5/00, A61P 37/00, A61P 35/00
// A61K38:20, A61K38:19
(86) International application number:
PCT/DK2002/000295
(87) International publication number:
WO 2002/089832 (14.11.2002 Gazette 2002/46)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 09.05.2001 DK 200100726
09.05.2001 US 289711 P

(71) Applicant: Alk-Abell A/S
2970 Horsholm (DK)

(72) Inventors:
  • JINQUAN, Tan
    DK-1954 Frederiksberg C (DK)
  • POULSEN, Lars, Kaergaard
    DK-2950 Vedbaek (DK)

(74) Representative: Olsen, Lars Pallisgaard et al
Zacco Denmark A/SHans Bekkevolds Allé 7
2900 Hellerup
2900 Hellerup (DK)

   


(54) PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING TH1 AND TH2 CELL RELATED DISEASES BY MODULATING THE TH1/TH2 RATIO.